PSORS1C1 and coronary artery disorder: Psoriasis is a well-established risk for CAD, and the psoriasis susceptibility 1 candidate 1 (PSORS1C1) gene expression is reduced in the present CAD cohort, and its locus is associated with psoriasis [36], rheumatoid arthritis [37], and capillary leak [38], and was recently associated with cardiometabolic parameters [39].